Not Signed In -
Retinopathy |
|
|
Retinopathy is a general term that refers to some form of non-inflammatory damage to the retina of the eye. Most commonly it is a problem with the blood supply that is the cause for this condition. Frequently, retinopathy is an ocular manifestation of systemic disease. Main causes of retinopathy are : diabetes - diabetic retinopathy arterial hypertension - hypertensive retinopathy prematurity of the newborn - retinopathy of prematurity (ROP) sickle cell anemia direct sunlight exposure ...
Wikipedia - [full article]
Retinopathy Clinical Trials
- Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity
ClinicalTrials.gov Identifier: NCT00000133 - Active, not recruiting
Retinopathy of Prematurity
- Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (the STOP-ROP Multicenter Trial)
ClinicalTrials.gov Identifier: NCT00000141 - Active, not recruiting
Retinopathy of Prematurity
- The Early Treatment for Retinopathy of Prematurity Study (ETROP)
ClinicalTrials.gov Identifier: NCT00027222 - Active, not recruiting
Retinopathy of Prematurity
- Treatment for Completers of the Study B7A-MC-MBCM
ClinicalTrials.gov Identifier: NCT00266695 - Active, not recruiting
Diabetic Retinopathy
- Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00545870 - Recruiting
Diabetic Retinopathy; Diabetic Macula Edema; Proliferative Diabetic Retinopathy
- Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
ClinicalTrials.gov Identifier: NCT00170742 - Active, not recruiting
Proliferative Diabetic Retinopathy
- Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)
ClinicalTrials.gov Identifier: NCT00542178 - Active, not recruiting
Diabetic Retinopathy
- Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
ClinicalTrials.gov Identifier: NCT00370721 - Recruiting
Diabetic Retinopathy
- Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
ClinicalTrials.gov Identifier: NCT00279669 - Recruiting
Retinopathy of Prematurity
- Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
ClinicalTrials.gov Identifier: NCT00346814 - Recruiting
Retinopathy of Prematurity
- Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00411333 - Recruiting
Diabetic Retinopathy
- Blood Factors and Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00005761 - Recruiting
Diabetic Retinopathy
- Reduction in the Occurrence of Center-Threatening Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00090519 - Recruiting
Diabetic Retinopathy
- Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
ClinicalTrials.gov Identifier: NCT00339001 - Recruiting
Retinopathy of Prematurity
- Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00347698 - Recruiting
Diabetic Retinopathy
- Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00407108 - Recruiting
Diabetic Retinopathy
- Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
ClinicalTrials.gov Identifier: NCT00516464 - Recruiting
Proliferative Diabetic Retinopathy
- Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
ClinicalTrials.gov Identifier: NCT00563043 - Recruiting
Non Proliferative Diabetic Retinopathy; Proliferative Diabetic Retinopathy
- Changes in Macular Thickness After Patterns Scan Laser
ClinicalTrials.gov Identifier: NCT00563628 - Recruiting
Non Proliferative Diabetic Retinopathy.; Proliferative Diabetic Retinopathy.
- Evaluation of Doxycyline for the Treatment of Nonproliferative and Early Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00511875 - Not yet recruiting
Diabetic Retinopathy
- Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00445003 - Recruiting
Proliferative Diabetic Retinopathy
- Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)
ClinicalTrials.gov Identifier: NCT00446381 - Recruiting
Proliferative Diabetic Retinopathy; Diabetic Macular Edema
- Efficacy and Safety of Octreotide Acetate in Microspheres in Patients with Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00130845 - Completed
Diabetic Retinopathy
- Efficacy and Safety of Octreotide Acetate in Microspheres in Patients with Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00131144 - Completed
Diabetic Retinopathy
- Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)
ClinicalTrials.gov Identifier: NCT00001612 - Completed
Diabetic Retinopathy
- DIabetic Retinopathy Candesartan Trials
ClinicalTrials.gov Identifier: NCT00252694 - Active, not recruiting
Type 2 Diabetes
- DIabetic Retinopathy Candesartan Trials.
ClinicalTrials.gov Identifier: NCT00252720 - Active, not recruiting
Type 1 Diabetes
- Diabetic Retinopathy Candesartan Trials
ClinicalTrials.gov Identifier: NCT00252733 - Active, not recruiting
Type 1 Diabetes
- Early Treatment Diabetic Retinopathy Study (ETDRS)
ClinicalTrials.gov Identifier: NCT00000151 - Completed
Blindness; Diabetic Retinopathy
- Extension Study of Long-Term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-Proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00248131 - Completed
Diabetic Retinopathy
- Extension Study of the Long-Term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-Proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00248157 - Completed
Diabetic Retinopathy
- Screening for Studies on Retinovascular Diseases
ClinicalTrials.gov Identifier: NCT00001733 - Recruiting
Diabetic Retinopathy; Macular Degeneration; Pathologic Neovascularization; Retinal Disease
- Use of Sucrose to Relieve Pain During Eye Exams in Infants
ClinicalTrials.gov Identifier: NCT00161694 - Recruiting
Apnea of Prematurity; Retinopathy of Prematurity; Pain Control
- A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
ClinicalTrials.gov Identifier: NCT00556114 - Enrolling by invitation
Retina; Glaucoma; Diabetic Retinopathy; Age-Related Macular Degeneration
- The Course of Response to Focal Photocoagulation for DME
ClinicalTrials.gov Identifier: NCT00442156 - Active, not recruiting
Diabetic Retinopathy; Diabetic Macular Edema
- A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
ClinicalTrials.gov Identifier: NCT00336323 - Active, not recruiting
Diabetic Retinopathy
- The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
ClinicalTrials.gov Identifier: NCT00000156 - Completed
Retinopathy of Prematurity
- Cysteine Supplementation in Critically Ill Neonates
ClinicalTrials.gov Identifier: NCT00254176 - Recruiting
Sepsis; Bronchopulmonary Dysplasia; Necrotizing Enterocolitis; Retinopathy of Prematurity; Systemic Inflammatory Response Syndrome
- Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
ClinicalTrials.gov Identifier: NCT00198471 - Active, not recruiting
Vitreous Detachment; Diabetic Retinopathy
- Diabetic Retinopathy Study (DRS)
ClinicalTrials.gov Identifier: NCT00000160 - Completed
Diabetic Retinopathy; Blindness
- Ocular Ischemic Syndrome
ClinicalTrials.gov Identifier: NCT00403195 - Recruiting
Retinal Degeneration; Diabetic Retinopathy
- Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy
ClinicalTrials.gov Identifier: NCT00155454 - Recruiting
Diabetes Mellitus; Diabetic Retinopathy; Vitreous Hemorrhage
- A Pilot Study for the Treatment of Iris Neovascularization With Macugen
ClinicalTrials.gov Identifier: NCT00295828 - Active, not recruiting
Iris Neovascularization; Diabetic Retinopathy
- Sorbinil Retinopathy Trial (SRT)
ClinicalTrials.gov Identifier: NCT00000159 - Completed
Diabetic Retinopathy; Diabetes Mellitus
- Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00443521 - Completed
Diabetic Retinopathy
- Single Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
ClinicalTrials.gov Identifier: NCT00349726 - Recruiting
Retinopathy of Prematurity
- Vitamin A and Very Low Birthweight Babies (VitAL)
ClinicalTrials.gov Identifier: NCT00417404 - Recruiting
Preterm Birth; Retinopathy of Prematurity
- Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
ClinicalTrials.gov Identifier: NCT00540930 - Active, not recruiting
Uveal Melanoma; Radiation Retinopathy; Radiation Maculopathy
- Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)
ClinicalTrials.gov Identifier: NCT00278486 - Recruiting
Retinal Disease
- Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00355680 - Completed
Diabetic Retinopathy
- Tracking Optical Coherence Tomography
ClinicalTrials.gov Identifier: NCT00343603 - Recruiting
Macular Degeneration; Glaucoma; Diabetic Retinopathy; Choroidal Disease
- Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging
ClinicalTrials.gov Identifier: NCT00343746 - Recruiting
Macular Degeneration; Glaucoma; Diabetic Retinopathy.
- Intravitreal Bevacizumab for Retinal Disorders
ClinicalTrials.gov Identifier: NCT00403026 - Recruiting
Wet AMD; Macular Oedema; Proliferative Diabetic Retinopathy
- Metabolic Mapping to Measure Retinal Metabolism
ClinicalTrials.gov Identifier: NCT00385333 - Recruiting
Macular Degeneration; Diabetic Retinopathy; Hippel-Landau Disease; Retina[ME]; Mitochondria
- Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training
ClinicalTrials.gov Identifier: NCT00500097 - Completed
Diabetic Retinopathy
- Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00407849 - Recruiting
Diabetic Retinopathy
- Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
ClinicalTrials.gov Identifier: NCT00524875 - Recruiting
Diabetic Retinopathy
- Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00423059 - Completed
Diabetic Retinopathy
- PST/Laser v. Laser Alone for CSME
ClinicalTrials.gov Identifier: NCT00229918 - Recruiting
Diabetic Retinopathy
- Diabetic Retinopathy Vitrectomy Study (DRVS)
ClinicalTrials.gov Identifier: NCT00000154 - Completed
Diabetic Retinopathy; Retinal Detachment; Vitreous Hemorrhage
- Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00069056 - Completed
Diabetic Retinopathy
- Diabetic Retinopathy and Visual Function Study
ClinicalTrials.gov Identifier: NCT00001346 - Completed
Diabetic Retinopathy; Macular Degeneration; Vision, Subnormal
- Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00287651 - Recruiting
Diabetes Mellitus, With Complications
- Continuous Positive Airway Pressure (CPAP) Versus Surfactant, and a Lower Versus a Higher Oxygen Saturation in 24 to 27 Week Preterm Infants
ClinicalTrials.gov Identifier: NCT00233324 - Recruiting
Bronchopulmonary Dysplasia; Retinopathy of Prematurity
- Long Term Follow-Up of Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00001395 - Completed
Blindness; Cataract; Diabetes Mellitus; Diabetic Retinopathy; Macular Degeneration
- Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling
ClinicalTrials.gov Identifier: NCT00556244 - Recruiting
Patients With Proliferative Diabetic Retinopathy Who Have Active Fibrovascular Proliferation
- Treatment of Refractory Diabetic Macular Edema With Infliximab
ClinicalTrials.gov Identifier: NCT00505947 - Recruiting
Diabetic Macular Edema; Visual Acuity; Diabetic Retinopathy
- Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
ClinicalTrials.gov Identifier: NCT00401115 - Completed
Diabetic Macular Edema; Diabetic Retinopathy
- Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00387582 - Recruiting
Diabetic Retinopathy; Diabetic Macular Edema
- Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00444600 - Recruiting
Diabetic Retinopathy; Diabetic Macular Edema
- Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00476918 - Recruiting
Diabetic Retinopathy; Diabetic Macular Edema
- Hypertension Related Damage to the Microcirculation in South Asian: Emergence, Predictive Power and Reversibility
ClinicalTrials.gov Identifier: NCT00331370 - Not yet recruiting
Hypertension; Diabetes; Cardiovascular Disease; Retinopathy
- Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study
ClinicalTrials.gov Identifier: NCT00041444 - Active, not recruiting
Atherosclerosis; Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Cerebrovascular Disorders; Heart Failure, Congestive; ...
- Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
- Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
ClinicalTrials.gov Identifier: NCT00211406 - Terminated
Diabetic Retinopathy
- Research Study in Patients with Persistent Macular Edema
ClinicalTrials.gov Identifier: NCT00035906 - Completed
Diabetes; Macular Edema; Diabetic Retinopathy; Retinal Disease; Uveitis, Posterior
- An Evaluation of a Coordinated Proactive Diabetes Eye Care Program
ClinicalTrials.gov Identifier: NCT00119535 - Completed
Diabetes Mellitus, Insulin-Dependent; Diabetic Retinopathy
- Krypton-Argon Regression of Neovascularization Study (KARNS)
ClinicalTrials.gov Identifier: NCT00000153 - Completed
Diabetic Retinopathy; Retinal Neovascularization; Diabetes Mellitus
- Lucentis for Cystoid Macular Edema for Non-Ischemic Retinopathy
ClinicalTrials.gov Identifier: NCT00464581 - Not yet recruiting
Cystoid Macular Edema
- Microvascular Reactivity.
ClinicalTrials.gov Identifier: NCT00259701 - Completed
Diabetes; Retinopathy; Vascular Pathology
- Heredity of Retinal Vessel Tortuosity
ClinicalTrials.gov Identifier: NCT00427063 - Completed
Retinopathy of Prematurity
- Vascular Endothelial Growth Factor in Stage V ROP
ClinicalTrials.gov Identifier: NCT00500396 - Completed
Retinopathy of Prematurity
- Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation
ClinicalTrials.gov Identifier: NCT00529594 - Completed
Proliferative Diabetic Retinopathy
- VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V
ClinicalTrials.gov Identifier: NCT00563121 - Completed
Retinopathy of Prematurity
- A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00414999 - Completed
Macular Degeneration; Diabetic Retinopathy
- Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
ClinicalTrials.gov Identifier: NCT00417833 - Completed
Diabetic Proliferative Retinopathy; Vascular Vein Oclussion; Choroidal Neovascularization
- 20- Versus 23- Gauge System for Pars Plana Vitrectomy
ClinicalTrials.gov Identifier: NCT00411970 - Completed
Diabetic Retinopathy; Macular Edema; Postoperative Complications; Vitreous Hemorrhage
- Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00231023 - Completed
Diabetic Retinopathy
- Retinal Blood Flow and Microthrombi in Type 1 Diabetes
ClinicalTrials.gov Identifier: NCT00406991 - Completed
Diabetes; Diabetic Retinopathy
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
ClinicalTrials.gov Identifier: NCT00198497 - Completed
Vitreous Hemorrhage; Diabetic Retinopathy
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
ClinicalTrials.gov Identifier: NCT00198510 - Completed
Vitreous Hemorrhage; Diabetic Retinopathy
- Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients
ClinicalTrials.gov Identifier: NCT00174824 - Completed
Diabetes Mellitus, Type 2
- Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00496405 - Completed
Diabetic Macular Edema; Diabetic Retinopathy
- Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
ClinicalTrials.gov Identifier: NCT00211367 - Terminated
Eye Injuries
- Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
ClinicalTrials.gov Identifier: NCT00211471 - Terminated
Severe Diabetic Retinopathy; Central Retinal Vein Occlusion; Chronic Inflammation; Infectious Diseases
Resources
- ¿Cuánto Sabe Sobre la Enfermedad Diabética del Ojo? (National Eye Institute, NIH, HHS)
- Diabetic Retinopathy: What You Should Know (National Eye Institute)
email this page
print this page
bookmark this page
feedback on this page
